The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...

A new combination pill has been given the green light by the National Institute for Health and Care Excellence (Nice) to ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

A new pill that promises to help endometriosis sufferers deal with the chronic disease’s debilitating symptoms was approved ...

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

Endometriosis causes chronic pain and fatigue when tissue similar to the womb lining grows outside the uterus. With diagnosis often taking up to 9 years, the availability of additional treatment ...

Unlike Elon Musk, Keir Starmer did not brandish a chainsaw to underline his commitment to reducing bureaucracy – but he might ...

The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition. | ITV National News ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

Copyright 2025 BBC. All rights reserved.  The BBC is not responsible for the content of external sites. Read about our approach to external linking.

The first-of-its-kind endometriosis pill provides hope for 1.5 million people in the UK affected by the condition ...